US should make it easier to study marijuana, the pediatric group said

11:42
US should make it easier to study marijuana, the pediatric group said -

The American Academy of Pediatrics (AAP) today urged that federal restrictions around marijuana be loosened to facilitate research on the medical potential, the drug benefit. In an online statement published in Pediatrics , the organization walked a tightrope between the use of recreational marijuana strongly discourage adolescents recognizing that medical applications, including youth children, have become more popular and more research is needed to better understand when and how the medication might help.

"[N] o studies have been done on the use of medical marijuana in children and adolescents," wrote Seth Ammerman, a pediatrician at Stanford University in Palo Alto, California, co-author of the new policy in a news story that accompany it. "therefore, the effects of the use of medical marijuana on the developing brain is unknown."

But because marijuana is now classified as a controlled Schedule I substance with a group of drugs that the US drug Enforcement administration (DEA) said to have "no currently accepted medical use in the United States," as heroin, ecstasy and LSD no study researcher might want to continue coming up with size dams: See here, here, and here AAP urges that marijuana fell in Annex II-category of drugs used to. treat patients who also need to be handled with care, because they have a "high potential for abuse," according to the DEA. Drugs in Schedule II include many drugs, such as morphine and oxycodone, and stimulants such as Ritalin and Adderall.

There was compelling reports of seriously ill children helped by cannabis. Some families have moved to states like Colorado that offer some medical marijuana strains. But rigorous studies that can transform data into stories are rare: Colorado, one of the 23 states (and the District of Columbia), where medical marijuana is legal for adults, recently greenlighted to 8.4 $ million in research grants on medication, including studies pediatric epilepsy and pediatric brain tumors. In June, the Food and Drug Administration has shared its examination at the request of DEA, marijuana could be removed from the Schedule category I. The new AAP policy can add to this drumbeat

the academy also addressed another issue related to cannabis in today's statement. He strongly opposed imprisoning adolescents for marijuana use, urging lawmakers and courts to promote the role of drug treatment strategies.

Previous
Next Post »
0 Komentar